These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11482446)

  • 1. Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells.
    Govindaraj A; Selvam R
    Urol Res; 2001 Jun; 29(3):194-8. PubMed ID: 11482446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
    Govindaraj A; Selvam R
    BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on calcium oxalate binding proteins: effect of lipid peroxidation.
    Selvam R; Kalaiselvi P
    Nephron; 2001 Jun; 88(2):163-7. PubMed ID: 11399920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxalate binding proteins in calcium oxalate nephrolithiasis.
    Selvam R; Kalaiselvi P
    Urol Res; 2003 Aug; 31(4):242-56. PubMed ID: 12856168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of experimental hyperoxaluria on renal calcium oxalate monohydrate binding proteins in the rat.
    Kalaiselvi P; Selvam R
    BJU Int; 2001 Jan; 87(1):110-6. PubMed ID: 11122003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel basic protein from human kidney which inhibits calcium oxalate crystal growth.
    Selvam R; Kalaiselvi P
    BJU Int; 2000 Jul; 86(1):7-13. PubMed ID: 10886075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyperoxaluria on the inhibitory activity of a 45-kD urinary protein.
    Selvam R; Balakrishnan S; Kalaiselvi P
    Nephron; 2002 Feb; 90(2):206-10. PubMed ID: 11818706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
    PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants.
    Selvam R
    Urol Res; 2002 Mar; 30(1):35-47. PubMed ID: 11942324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
    Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
    PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enlargement of a lower pole calcium oxalate stone: a theoretical examination of the role of crystal nucleation, growth, and aggregation.
    Kavanagh JP
    J Endourol; 1999 Nov; 13(9):605-10. PubMed ID: 10608510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.